22
| 4 | 2011
Klinisk Biokemi i Norden
giske tester kan gi et stort antall falskt positive eller
falskt negative resultater, og bør derfor kun benyttes
til initiell screening. Men man må også være opp-
merksom på at immunologiske tester normalt ikke kan
påvise bruk eller misbruk av lavdose-benzodiazepiner.
Referanser
1.
Choo RE, Huestis MA. Oral fluid as a diagnos-
tic tool. Clin Chem Lab Med 2004;42:1273-87.
2.
Drummer OH. Drug testing in oral fluid. Clin
Biochem Rev 2006;27:147-59.
3.
Bosker WM, Huestis MA. Oral fluid testing for
drugs of abuse. Clin Chem 2009;55:1910-31.
4.
Wille SMR, Raes E, Lillsunde P, Gunnar T,
Laloup M, Samyn N, et al. Relationship bet-
ween oral fluid and blood concentrations of
drugs of abuse in drivers suspected of DUID.
Ther Drug Monit 2009;31:511-9.
5.
Gjerde H, Mordal J, Christophersen AS, Bram-
ness JG, Morland J. Comparison of drug con-
centrations in blood and oral fluid collected
with the Intercept sampling device. J Anal
Toxicol 2010;34:204-9.
6.
Jones AW. Inter- and intra-individual variations
in the saliva/blood alcohol ratio during ethanol
metabolism inman. Clin Chem 1979;25:1394-8.
7.
Townsend S, Fanning L, O’Kennedy R. Salivary
Analysis of Drugs
-
Potential and Difficulties.
Anal Lett 2008;41:925-48.
8.
Pehrsson A, Blencowe T, Vimpari K, Langel
K, Engblom C, Lillsunde P. An Evaluation of
On-Site Oral Fluid Drug Screening Devices
DrugWipe((R)) 5+ and Rapid STAT((R)) Using
Oral Fluid for Confirmation Analysis. J Anal
Toxicol 2011;35:211-8.
9.
Wille SM, Samyn N, Ramirez-Fernandez MM,
De BG. Evaluation of on-site oral fluid screening
using Drugwipe-5(+), RapidSTAT and Drug
Test 5000 for the detection of drugs of abuse in
drivers. Forensic Sci Int 2010;198:2-6.
10.
Goessaert AS, Pil K, Veramme J, Verstra-
ete A. Analytical evaluation of a rapid on-
site oral fluid drug test. Anal Bioanal Chem
2010;396:2461-8.
11.
Blencowe T, Pehrsson A, Lillsunde P, Vimpari
K, Houwing S, Smink B, et al. An analytical
evaluation of eight on-site oral fluid drug
screening devices using laboratory confirma-
tion results from oral fluid. Forensic Sci Int
2011;208:173-9.
12.
Gallardo E, Queiroz JA. The role of alternative
specimens in toxicological analysis. Biomed
Chromatogr 2008;22:795-821.
13.
Lacey JH, Kelley-Baker T, Furr-Holden D,
Brainard K, Moore C. Pilot test of new road-
side survey methodology for impaired driving.
DOT HS 810 704. Washington: National High-
way Traffic Safety Administration; 2007.
14.
Lacey JH, Kelley-Baker T, Furr-Holden D,
Voas RB, Romano E, Ramirez A, et al. 2007
national roadside survey of alcohol and drug
use by drivers - drug results. DOT HS 811 249.
Washington: National Highway Safety Admi-
nistration; 2009.
15.
Fendrich M, Johnson TP, Wislar JS, Hubbell A,
Spiehler V. The utility of drug testing in epi-
demiological research: results from a general
population survey. Addiction 2004;99:197-208.
16.
Gjerde H, Christophersen AS, Moan IS, Yttre-
dal B, Walsh JM, Normann PT, et al. Use of
alcohol and drugs by Norwegian employees: a
pilot study using questionnaires and analysis
of oral fluid. J Occup Med Toxicol 2010;5:13.
17.
Verstraete AG. Detection times of drugs of
abuse in blood, urine, and oral fluid. Ther Drug
Monit 2004;26:200-5.
18.
Vindenes V, Yttredal B, Oiestad EL, Waal H,
Bernard JP, Morland JG, et al. Oral fluid is a
viable alternative for monitoring drug abuse:
detection of drugs in oral fluid by liquid
chromatography-tandem mass spectrometry
and comparison to the results from urine sam-
ples from patients treated with Methadone or
Buprenorphine. J Anal Toxicol 2011;35:32-9.
19.
Langel K, Engblom C, Pehrsson A, Gunnar T,
Ariniemi K, Lillsunde P. Drug testing in oral
fluid-evaluation of sample collection devices.
J Anal Toxicol 2008;32:393-401.
20.
Mecarelli OM, Voti PLM, Pro SM, Romolo
FSP, Rotolo MP, Pulitano PM, et al. Saliva
and Serum Levetiracetam Concentrations in
Patients With Epilepsy. Ther Drug Monit
2007;29:313-8.
(
Fortsat fra side 21)
